Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Paclitaxel/erlotinib/gemcitabine

Lack of efficacy and pneumonitis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mody J, et al. Pancreatic Adenocarcinoma with Co-Occurrence of KRAS and EGFR Mutations: Case Report and Literature Review. Case Reports in Oncology 17 : 399-406, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.1159/000536552 Mody J, et al. Pancreatic Adenocarcinoma with Co-Occurrence of KRAS and EGFR Mutations: Case Report and Literature Review. Case Reports in Oncology 17 : 399-406, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.1159/000536552
Metadaten
Titel
Paclitaxel/erlotinib/gemcitabine
Lack of efficacy and pneumonitis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55765-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Immune-globulin

Case report

Multiple drugs